Leavell Investment Management Inc. Has $6.15 Million Holdings in Albemarle Co. (ALB)

Leavell Investment Management Inc. raised its stake in Albemarle Co. (NYSE:ALB) by 2.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 48,099 shares of the specialty chemicals company’s stock after purchasing an additional 1,000 shares during the quarter. Leavell Investment Management Inc.’s holdings in Albemarle were worth $6,151,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. Scotia Capital Inc. grew its stake in shares of Albemarle by 0.5% in the 2nd quarter. Scotia Capital Inc. now owns 2,022 shares of the specialty chemicals company’s stock valued at $213,000 after purchasing an additional 10 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Albemarle by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after buying an additional 20 shares in the last quarter. L & S Advisors Inc boosted its stake in shares of Albemarle by 2.2% in the second quarter. L & S Advisors Inc now owns 4,200 shares of the specialty chemicals company’s stock valued at $443,000 after buying an additional 90 shares in the last quarter. Thrivent Financial For Lutherans boosted its stake in shares of Albemarle by 2.2% in the second quarter. Thrivent Financial For Lutherans now owns 4,240 shares of the specialty chemicals company’s stock valued at $447,000 after buying an additional 90 shares in the last quarter. Finally, Zacks Investment Management boosted its stake in shares of Albemarle by 2.4% in the second quarter. Zacks Investment Management now owns 4,767 shares of the specialty chemicals company’s stock valued at $503,000 after buying an additional 111 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

A number of research firms recently weighed in on ALB. Loop Capital began coverage on Albemarle in a research note on Thursday, September 28th. They issued a “buy” rating and a $150.00 price target on the stock. UBS Group lifted their price target on Albemarle from $123.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, November 9th. Royal Bank of Canada restated a “buy” rating and issued a $149.00 price target on shares of Albemarle in a research note on Wednesday, October 18th. KeyCorp lifted their price target on Albemarle from $125.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, October 16th. Finally, Jefferies Group lifted their price target on Albemarle from $156.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, November 14th. Ten research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Albemarle currently has an average rating of “Buy” and a consensus target price of $128.38.

Albemarle Co. (NYSE ALB) traded down $2.48 on Thursday, reaching $132.96. The company’s stock had a trading volume of 884,600 shares, compared to its average volume of 1,116,629. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.56 and a current ratio of 2.11. The stock has a market capitalization of $14,880.00, a P/E ratio of 47.49, a price-to-earnings-growth ratio of 1.73 and a beta of 1.69. Albemarle Co. has a one year low of $90.08 and a one year high of $144.99.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 EPS for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.01. The company had revenue of $755.00 million for the quarter, compared to the consensus estimate of $732.19 million. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. Albemarle’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. equities analysts anticipate that Albemarle Co. will post 4.46 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 15th were issued a $0.32 dividend. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.96%. Albemarle’s dividend payout ratio (DPR) is 45.71%.

TRADEMARK VIOLATION NOTICE: This piece was originally published by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://weekherald.com/2018/01/11/leavell-investment-management-inc-has-6-15-million-holdings-in-albemarle-co-alb.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply